Skip to main content

Your search for “pharmacology” returned 281 results

UC San Diego and Mount Sinai Receive $8.5M NIH Award for Data Integration Hub

October 11, 2023

Researchers at UC San Diego and the Icahn School of Medicine at Mount Sinai have been awarded an $8.5 million grant to create a data integration hub aimed at accelerating novel therapeutics and cures for diseases within initiatives supported by the NIH Common Fund.

Researchers Unveil New Approach to Flip the Script on Drug Addiction

February 1, 2024

UC San Diego scientists are working to flip the script on drug addiction with a $1.3 million grant from the W.M. Keck Foundation. Their new approach, called negative feedback chemogenetics, works by leveraging the body’s biochemical feedback processes to disrupt pathways associated with addiction.

Newly Discovered HIV Genome Modification May Put a Twist on Vaccine and Drug Design

February 22, 2016

Researchers at University of California, San Diego School of Medicine have discovered that HIV infection of human immune cells triggers a massive increase in methylation, a chemical modification, to both human and viral RNA, aiding replication of the virus. The study, published February 22, 2016 in Nature Microbiology, identifies a…

Compounds in Desert Creosote Bush Could Treat Giardia and “Brain-eating” Amoeba Infections

August 15, 2017

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a desert plant common to the Southwestern United States, exhibit potent anti-parasitic activity against the protozoa responsible for…

Flipping a Metabolic Switch to Slow Tumor Growth

August 12, 2020

The enzyme serine palmitoyl-transferase can be used as a metabolically responsive “switch” that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug. 12 in the journal Nature.

Novel Drug Prevents Amyloid Plaques, a Hallmark of Alzheimer’s Disease

March 2, 2021

Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.

Researchers Discover Hidden SARS-CoV-2 ‘Gate’ That Opens to Allow COVID Infection

August 19, 2021

New visualizations of SARS-CoV-2 have allowed researchers to discover how the virus enters and infects healthy human cells. They found that glycan sugar molecules act as infection “gates” to our cell’s receptors.

Can Ancient Botanical Therapies Help Treat COVID-19?

November 12, 2021

…epidemics, while the Greek pharmacologist Pedanius Dioscorides prescribed agarikon to treat pulmonary infections 2,300 years ago. Though Western medicine still regards much of integrative medicine as lacking empirical, evidence-based proof, some of its ideas are gaining wider acceptance, such as acupuncture to treat pain and the herbal extract artemisinin to…

Bioengineering Alumnus on COVID-19 Antiviral Pill Development Team

February 24, 2022

…of these studies. Communication across disciplines with chemists, biologist, pharmacologist, clinicians, and many more was essential to discovering the molecule, profiling it, and clinically testing it so that we could help people fighting this devastating disease today. I am incredibly grateful to each and every one of them.

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

April 22, 2019

University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.

Category navigation with Social links